米托蒽醌脂质体对卵巢癌细胞增殖、迁移及干性的影响OA
Effects of Mitoxantrone liposomes on the proliferation,migration and stemness in ovarian cancer cells
目的 探讨米托蒽醌脂质体(Lipo-MIT)对卵巢癌细胞增殖、迁移及癌症干细胞(CSCs)干性的影响,并基于磷脂酰肌醇3激酶(PI3K)/蛋白激酶B(AKT)通路探讨其作用机制.方法 通过体外实验考察Lipo-MIT对细胞增殖、迁移和CSCs干性特征的影响.构建裸鼠人卵巢癌细胞A2780异种移植瘤模型,探究2、5 mg/kg Lipo-MIT对荷瘤裸鼠安全性以及体内肿瘤生长、肿瘤组织病理特征的影响,并考察Lipo-MIT对细胞与肿瘤组织中PI3K/AKT通路、上皮-间充质转化、干性相关蛋白表达的调控作用.结果Lipo-MIT对A2780、SK-OV3和OV-CAR5细胞的半数抑制浓度分别为0.72、5.41、2.77 μmol/L;与溶剂对照(0.1%二甲基亚砜)比较,0.5~2.5 μmol/L Lipo-MIT可显著降低细胞克隆形成率、缩短细胞迁移距离、减少迁移细胞数、下调神经钙黏素(N-cadherin)蛋白表达、上调上皮钙黏素(E-cadherin)蛋白表达(P<0.05),并降低肿瘤球形成率、下调乙醛脱氢酶1A1(ALDH1A1)蛋白表达(P<0.05);1.0、2.5 μmol/L Lipo-MIT可显著降低干细胞成球概率和下调细胞中性别决定区Y框蛋白2表达(P<0.05).2、5 mg/kg Lipo-MIT对荷瘤裸鼠的体重、饮食量和饮水量及脏器(心、肝、脾、肺、肾)指数均无明显影响(P>0.05),可显著改善肿瘤组织的病理变化,并可显著抑制肿瘤组织中N-cadherin和CD133、ALDH1A1(仅5 mg/kg Lipo-MIT)蛋白表达(P<0.05),上调E-cadherin(仅5 mg/kg Lipo-MIT)蛋白表达(P<0.05).不同浓度/剂量Lipo-MIT均可显著降低细胞/肿瘤组织中PI3K、AKT蛋白的磷酸化水平(P<0.05).结论 Lipo-MIT可通过抑制PI3K/AKT通路活性来抑制卵巢癌细胞的增殖、迁移和干性.
OBJECTIVE To investigate the effects of Mitoxantrone liposomes(Lipo-MIT)on the proliferation,migration and cancer stem cell(CSCs)stemness of ovarian cancer cells,as well as to explore its mechanism of action based on the phosphoinositide 3-kinase(PI3K)/protein kinase B(AKT)pathway.METHODS The effects of Lipo-MIT on cell proliferation,migration and the stemness characteristics of CSCs were investigated through in vitro experiments.A human ovarian cancer A2780 cells xenograft tumor model of nude mouse was established to explore the effects of Lipo-MIT at doses of 2 and 5 mg/kg on the safety of tumor-bearing mice,as well as in vivo tumor growth and the pathological characteristics of tumor tissues.The influence of Lipo-MIT on the expression levels of PI3K/AKT pathway-related proteins,epithelial-mesenchymal transition related proteins,and stemness related proteins in both cells and tumor tissues was also investigated.RESULTS The half maximal inhibitory concentrations of Lipo-MIT against A2780,SK-OV3,and OV-CAR5 cells were 0.72,5.41,and 2.77 μmol/L,respectively.Compared with solvent control(0.1%dimethyl sulfoxide),0.5-2.5 μmol/L Lipo-MIT significantly reduced the cell colony formation rate,shortened the cell migration distance,decreased the number of migrated cells,down-regulated the protein expression of N-cadherin,up-regulated the protein expression of E-cadherin(P<0.05),and also decreased the stem cell sphere formation frequency and down-regulated the protein expression of aldehyde dehydrogenase 1A1(ALDH1A1)(P<0.05).Additionally,1.0 and 2.5 μmol/L Lipo-MIT significantly reduced the stem cell sphere formation probability and down-regulated the protein expression of sex determining region Y box protein 2 in cells(P<0.05).In vivo experimental results demonstrated that 2,5 mg/kg Lipo-MIT had no significant effects on the body weight,food intake,water intake,and organ(heart,liver,spleen,lung,and kidney)indices of tumor-bearing nude mice(P>0.05),but could significantly improve the pathological changes of tumor tissues and remarkably inhibit the protein expressions of N-cadherin,CD133 and ALDH1A1(only at 5 mg/kg Lipo-MIT),up-regulate the expression of E-cadherin(only at 5 mg/kg Lipo-MIT)in tumor tissues(P<0.05).Lipo-MIT at different concentrations/doses significantly reduced the phosphorylation levels of PI3K and AKT proteins in cells/tumor tissues(P<0.05).CONCLUSIONS Lipo-MIT can inhibit the proliferation and migration of ovarian cancer cells and the stemness by suppressing the activity of the PI3K/AKT pathway.
王冬;张悦;储百旺;孙华
天津医科大学肿瘤医院药学部/国家恶性肿瘤临床医学研究中心/天津市肿瘤防治重点实验室/天津市恶性肿瘤临床医学研究中心,天津 300060||天津市肿瘤医院空港医院药学部,天津 300308天津科技大学生物工程学院,天津 300457天津市肿瘤医院空港医院药学部,天津 300308天津科技大学生物工程学院,天津 300457
医药卫生
米托蒽醌脂质体卵巢癌癌症干细胞PI3K/AKT通路
mitoxantrone liposomesovarian cancercancer stem cellsPI3K/AKT pathway
《中国药房》 2026 (1)
42-48,7
中国医药卫生事业发展基金会医学科研项目(No.HXHY2024KY0001)北京医学奖励基金会课题(No.YXJL-2022-0435-0392)天津市医学重点学科建设项目(No.TJYXZDXK-3-003A)
评论